Results 121 to 130 of about 19,560 (233)
Hatem M Marey, Amin F EllakwaDepartment of Ophthalmology, Faculty of Medicine, Menoufiya University, Shibin el Kom, EgyptPurpose: To demonstrate the role of intravitreal bevacizumab in regression of iris neovascularization, and intraocular pressure (IOP)
Marey HM, Ellakwa AF
doaj
Intravitreal ranibizumab (Lucentis®) in the treatment of retinal angiomatous proliferation (RAP) [PDF]
Background: Retinal angiomatous proliferation (RAP) is a distinct variant of neovascular age-related macular degeneration (AMD). The aim of this study is to evaluate the functional and anatomic outcome after intravitreal ranibizumab (Lucentis) treatment ...
Ambresin, Aude +5 more
core
Intravitreal Bevacizumab: Indications And Complications.
Bevacizmab is still an unlicensed drug for intraocular use in spite of the fact that it has shown comparable efficacy to other anti-vascular endothelial growth factors (anti-VEGF) medications in some large sample randomized control trails. Although repackaged bevacizumab has got safety concerns but its use is growing because of easy availability and ...
Sanaullah, Jan +3 more
openaire +1 more source
Using intravitreal bevacizumab (Avastin®) – Indian Scenario
Atul Kumar, Raghav Ravani
openaire +3 more sources
A 14-year-old girl presenting with visual loss in both eyes was diagnosed to have healed toxoplasma retinochoroiditis in the right eye with active choroidal neovascularization (CNV) secondary to toxoplasmosis in the left.
Rishi Pukhraj +2 more
doaj
Aim: To compare the effect of intravitreal bevacizumab and triamcinolone in patients with macular edema after central retinal vein occlusion (CRVO), presenting with poor visual acuity.
Lim Ji, Na Kyeong-Ik
doaj
Evaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration. [PDF]
Sahin O +4 more
europepmc +1 more source
Nisha V Shah,1 Samuel K Houston,1 Arnold Markoe,2 Timothy G Murray1,2,3 1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA; 2Department of Radiation Oncology, University of Miami ...
Shah NV, Houston SK, Markoe A, Murray TG
doaj
Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity. [PDF]
Pawar N +5 more
europepmc +1 more source

